Cargando…
Update for Advance CAR-T Therapy in Solid Tumors, Clinical Application in Peritoneal Carcinomatosis From Colorectal Cancer and Future Prospects
Latest advances in the field of cancer immunotherapy have developed the (Chimeric Antigen Receptor) CAR-T cell therapy. This therapy was first used in hematological malignancies which obtained promising results; therefore, the use of CAR-T cells has become a popular approach for treating non-solid t...
Autores principales: | Qian, Siyuan, Villarejo-Campos, Pedro, Guijo, Ismael, Hernández-Villafranca, Sergio, García-Olmo, Damián, González-Soares, Sara, Guadalajara, Héctor, Jiménez-Galanes, Santos, Qian, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990899/ https://www.ncbi.nlm.nih.gov/pubmed/35401510 http://dx.doi.org/10.3389/fimmu.2022.841425 |
Ejemplares similares
-
Understanding CAR T cell therapy and its role in ovarian cancer and peritoneal carcinomatosis from ovarian cancer
por: Domínguez-Prieto, Víctor, et al.
Publicado: (2023) -
The Role of CAR-T Cells in Peritoneal Carcinomatosis from Gastric Cancer: Rationale, Experimental Work, and Clinical Applications
por: Qian, Siyuan, et al.
Publicado: (2021) -
Under the Hood: Understanding the Features of Mucin in Pseudomyxoma Peritonei
por: Villarejo-Campos, Pedro, et al.
Publicado: (2023) -
Intraperitoneal collagenase as a novel therapeutic approach in an experimental model of colorectal peritoneal carcinomatosis
por: García-Olmo, D., et al.
Publicado: (2021) -
Toxicity study in a pig model of intraperitoneal collagenase as an “enzymatic scalpel” directed to break stroma in order to generate a new perspective for peritoneal carcinomatosis approach: an experimental research
por: Garcia-Arranz, M., et al.
Publicado: (2022)